摘要
过去认为涎腺肿瘤属于放射线不敏感性的疾病,然而现在,临床放疗的成功经验和报告令人信服地证明,放射治疗在涎腺肿瘤的治疗上已占有重要地位。对涎腺恶性肿瘤,手术联合术后放疗比单用手术治疗有更高的局部控制率;对不可切除的晚期肿瘤,放疗也可能使患者获得长期生存机会;对术后复发的腮腺多形性腺瘤,手术联合术后放疗能明显降低复发率。放疗新设备、新技术和新方法(三维适形放疗与调强放疗、现代近距离放疗、同步放化疗等)的应用与放射治疗效果的提高有关。
Salivary gland tumors were considered to be radioresistant in the past. However, at present, radiotherapy plays an important role because there are more convincing successful evidence of medical reports and clinical experiences in the radiotherapy for the tumors. For salivary gland carcinomas, combined surgery and postoperative radiotherapy achieved better local control rate than surgery alone. For the inoperable later stage tumor, radiation therapy may get a possibility of long-term survival for the patients. For the recurrent pleomorphic adenoma of the parotid gland, re-operation and postoperative radiotherapy descended local recurrent rate of the tumor. New radiation equipments, techniques and methods （e.g. 3-dimensional conformal radiotherapy, intensity-modulated radiotherapy, modern bracytherapy and concomitant radioehemotherapy） are related to the improvement.
出处
《口腔颌面外科杂志》
CAS
2010年第3期153-157,共5页
Journal of Oral and Maxillofacial Surgery
基金
上海市科学技术委员会资助项目(08DZ2271100)
关键词
涎腺肿瘤
放射治疗
术后放射治疗
salivary gland tumor
radiation therapy
postoperative radiotherapy
